Dr. Li is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4500 San Pablo Rd S
Jacksonville, FL 32224Phone+1 904-953-2000
Summary
- Dr. Shenduo Li is an internal medicine doctor based in Jacksonville, FL, with subspecialties in Hematology/Oncology. He completed his residency in Internal Medicine between 2015 and 2018 at the Jacobi Medical Center/Albert Einstein College of Medicine. He completed a fellowship in Hematology and Medical Oncology from Mayo Clinic College of Medicine and Science (Jacksonville) from 2021 to 2024. In his professional career, he worked as a resident at NYC Health + Hospitals / Jacobi from 2015 to 2018. He was a clinical fellow at Mayo Clinic Hospital in Florida from 2021 to 2024, and subsequently joined as faculty member specialized in thoracic, head and neck oncology. Dr. Li has several published works in prestigious journals including Cancers, Frontiers in Oncology, Current Oncology Reports, and JTO Clinical and Research Reports, with some being cited by other publications.
Education & Training
- Mayo Clinic College of Medicine and Science (Jacksonville)Fellowship, Hematology and Medical Oncology, 2021
- Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 2015 - 2018
- Peking University Health Science CenterClass of 2009
Certifications & Licensure
- FL State Medical License 2021 - 2025
- WA State Medical License 2018 - 2022
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 3 citationsImmune-Related Adverse Events in Patients with Lung Cancer.Guilherme Sacchi de Camargo Correia, Tanmayi Pai, Shenduo Li, Dana Connor, Yujie Zhao
Current Oncology Reports. 2023-11-01 - 20 citationsEfficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.Lingzhi Hong, Muhammad Aminu, Shenduo Li, Xuetao Lu, Milena Petranovic
Nature Communications. 2023-02-08 - 53 citationsModel of Tumor Dormancy/Recurrence after Short-Term ChemotherapyShenduo Li, Margaret Kennedy, Sturgis Payne, Kelly M. Kennedy, Victoria L. Seewaldt
Plos One. 2014-05-20
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: